Work

A novel assay for studying the hepcidin-ferroportin axis and its application in characterizing a new SLC40a1 mutation

Year: 2017
Type: article
Abstract: The hepcidin–ferroportin axis underlies the pathophysiology of many iron‐associated disorders. The clinical presentation and treatment of ferroportin disease is highly dependent on the functional consequences of the causative mutation: transport‐deficient or hepcidin‐resistant. The aims of this study were to identify the molecular basis of disease in a patient with iron overload, and to use a novel antibody, which we developed, to characterize ferroportin variants and their sensitivity to hepcidin.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W2801096445
FWCI:
Cites:
Cited by:
Related to: 10